TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.
Source: sleepreviewmag.com
Wakefulness Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wakefulness Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wakefulness Test Today - Breaking & Trending Today
Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment
Alkermes will present new data for its investigational narcolepsy treatment, ALKS 2680, at SLEEP 2024 in Houston.
Source: sleepreviewmag.com
Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -
Source: finanznachrichten.de
Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
BOSTON and LONDON, April 22, 2024 -- Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today...
Source: marketscreener.com
FDA OKs Phase 1 Trial of Narcolepsy Drug Candidate ORX750
Centessa has received FDA clearance to start a phase 1 trial of ORX750, aimed at narcolepsy and other sleep-wake disorders.
Source: sleepreviewmag.com